Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended October 31, 2007
Business Overview: The Company manufactures laboratory furniture and equipment. Operations are segmented into Domestic and International divisions.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Oct 31, 2007 | 6 Months Ended Oct 31, 2007 |
|---|---|---|
| Net Sales | $24,727 | $45,511 |
| Gross Profit | $5,553 | $9,816 |
| Gross Margin | 22.5% | 21.6% |
| Operating Earnings | $2,183 | $3,298 |
| Net Earnings | $1,212 | $1,886 |
| Diluted EPS | $0.47 | $0.74 |
| Cash from Operations (6mo) | $1,700 | |
| Short-term Borrowings | $2,336 (as of Oct 31, 2007) | |
| Working Capital | $14.0 million (as of Oct 31, 2007) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 15.6% for the quarter and 11.9% for the six-month period compared to the prior year. Domestic sales grew 17.9% (quarter) and 13.0% (six months), while international sales grew 6.9% and 6.4% respectively.
- Margin Expansion: Gross profit margins improved significantly to 22.5% (quarter) and 21.6% (six months) from 19.1% and 17.7% in the prior year. Management attributes this to manufacturing efficiencies and cost savings from alternate raw material sources.
- Profitability: Operating earnings more than doubled for both periods compared to the prior year ($2.18M vs $1.18M for the quarter; $3.30M vs $1.67M for six months). Net earnings increased 113% for the quarter and 169% for the six-month period.
- Expense Management: Operating expenses increased in absolute dollars due to higher incentive plan costs and sales/marketing expenses, but remained stable as a percentage of sales (13.6% for the quarter).
- Debt Reduction: Short-term borrowings decreased from $3.49 million at April 30, 2007, to $2.34 million at October 31, 2007, resulting in lower interest expense.
Guidance, Outlook, and Risks
- Outlook: Management expects the last six months of fiscal year 2008 to be profitable and improved over the same period last year. Demand is tied to laboratory construction projects.
- Order Backlog: Total order backlog was $54.9 million at October 31, 2007, up from $34.3 million at October 31, 2006.
- Risks: Earnings may be impacted by rising raw material costs (stainless steel, wood, epoxy resin). The Company's ability to pass these costs to customers without affecting sales volume is a key uncertainty.
- Capital Structure Update: On December 10, 2007, the Company entered into a new $12 million revolving credit facility with Bank of America, maturing September 30, 2010. Interest rates are LIBOR plus a margin of 1.45% to 2.05%.
- Executive Compensation: A Change of Control Employment Agreement was approved for a Vice President, and the Incentive Bonus Plan was amended to provide for pro-rated payouts upon a Change of Control.
Investor Verification Checklist
- Raw Material Costs: Verify the trajectory of stainless steel, wood, and epoxy resin prices and the Company's ability to implement price increases.
- Construction Pipeline: Assess the health of the laboratory construction market, which drives demand for the Company's products.
- Debt Covenants: Review the financial covenants in the new $12 million credit facility to ensure compliance with fixed charge coverage ratios.
- Minority Interests: Note that minority interests in foreign subsidiaries reduced net earnings by $230,000 for the six-month period; verify the performance of these non-wholly-owned subsidiaries.
- Inventory Levels: Inventories increased to $6.42 million; confirm that this aligns with the $54.9 million order backlog and does not indicate obsolescence.